Cargando…
Role of janus kinase inhibitors in the treatment of alopecia areata
Alopecia areata (AA) is a common hair loss disorder worldwide with characteristic exclamation mark hairs. Although AA is self-limited, it can last for several months or even years in some patients. Currently, there is no US Food and Drug Administration-approved treatment for AA. Many off-label treat...
Autores principales: | Triyangkulsri, Korn, Suchonwanit, Poonkiat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6067625/ https://www.ncbi.nlm.nih.gov/pubmed/30100707 http://dx.doi.org/10.2147/DDDT.S172638 |
Ejemplares similares
-
Alopecia Areata: An Autoimmune Disease of Multiple Players
por: Suchonwanit, Poonkiat, et al.
Publicado: (2021) -
Fibrosing Alopecia in a Pattern Distribution: A Case Report and Literature Review
por: Triyangkulsri, Korn, et al.
Publicado: (2019) -
Application of Topical Immunotherapy in the Treatment of Alopecia Areata: A Review and Update
por: Mahasaksiri, Thipprapai, et al.
Publicado: (2021) -
Translational Positioning of Janus Kinase (JAK) Inhibitors in Alopecia Areata
por: Blume-Peytavi, Ulrike, et al.
Publicado: (2015) -
Trichoscopic Features of Syphilitic Alopecia and Alopecia Areata: A Comparative Study
por: Tejapira, Kasama, et al.
Publicado: (2023)